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Abstract
Hypothesis tests based on linear models are widely accepted by organizations that
regulate clinical trials. These tests are derived using strong assumptions about the
data-generating process so that the resulting inference can be based on parametric
distributions. Because these methods are well understood and robust, they are some-
times applied to data that depart from assumptions, such as ordinal integer scores.
Permutation tests are a nonparametric alternative that require minimal assumptions
which are often guaranteed by the randomization that was conducted. We compare
analysis of covariance (ANCOVA), a special case of linear regression that incorpo-
rates stratification, to several permutation tests based on linear models that control
for pretreatment covariates. In simulations of randomized experiments using models
which violate some of the parametric regression assumptions, the permutation tests
maintain power comparable to ANCOVA. We illustrate the use of these permutation
tests alongside ANCOVA using data from a clinical trial comparing the effectiveness
of two treatments for gastroesophageal reflux disease. Given the considerable costs
and scientific importance of clinical trials, an additional nonparametric method, such
as a linear model permutation test, may serve as a robustness check on the statistical
inference for the main study endpoints.
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1 Background
A hypothesis test is a statistical method for determining whether observed data is con-
sistent with a belief about the process that generated the data. Medical experiments use
hypothesis testing to assess the evidence that a treatment affects one or more clinically
relevant outcomes. The simplest version of this experiment has been studied for nearly a
century (see Fisher (1935) and (Neyman, 1923, 1990 translation) for early references). This
experiment involves randomly assigning two treatments to a fixed number of individuals in
a group and measuring a single outcome. One can conduct hypothesis tests and construct
confidence intervals for the estimated treatment effect by exploiting the fact that the dif-
ference in average outcomes between the two treatment groups is asymptotically normal
with a variance that can be estimated from the data.
The goal of a randomized experiment is to draw causal inferences about the efficacy
of a treatment. Thus, it makes sense to analyze experiments in the context of potential
outcomes, where every individual has a counterfactual outcome for each of the treatments
(Holland (1986)) Experiments are an attempt to estimate the counterfactual outcomes by
randomly assigning treatments. Random assignment of treatment ensures that pretreat-
ment covariates are balanced between treatment groups on average, across all possible
randomizations, making treatment groups comparable to each other.
However, in any particular randomization, there may be imbalances. If the imbalanced
variables are associated with the outcome, then even when treatment has no effect, there
may be differences in outcomes between treatment groups. Adjusting for such covariates
can reduce the variability of treatment effect estimates and yield more powerful hypothesis
tests.
Stratification, sometimes called blocking, is one method to control for covariates that
are known a priori to be associated with the outcome. Strata are groups of individuals
with similar levels of a covariate. These groups are defined during the design stage (i.e.
before outcome data are collected). Random assignment of treatments is conducted within
each stratum, independently across strata. This guarantees that the stratification variable
is balanced between treatment groups. A common stratification variable in clinical exper-
iments is location: individuals often come from many locations because it is difficult to
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recruit a sufficient number of participants at one site, especially when the object of study
is a rare disease or a rare outcome.
Linear regression is another method to control for imbalanced baseline covariates. It
is done during the data analysis stage. In its simplest form, linear regression projects the
outcomes onto the plane that best summarizes each variable’s relationship to the outcome.
The coefficient of any particular covariate answers the question, if we were to hold fixed
all other variables and increase this variable by one unit, how much would we expect the
outcome to change? This model posits a linear relationship between covariates, treatment,
and outcome; if the true relationship is not linear, then linear regression gives the best
linear approximation to the conditional expectation of the outcome. It is standard to use
analysis of covariance (ANCOVA) to incorporate stratification in a linear model. ANCOVA
is a particular case of linear regression that allows the mean outcome to vary from stratum
to stratum. This amounts to fitting a plane to each stratum, with the constraint that they
have a common slope.
Hypothesis testing of estimated coefficients requires even stronger assumptions which
are not guaranteed by the experimental design. When the assumptions hold, a hypothesis
test for a treatment effect amounts to a hypothesis test of the coefficient for treatment in
the ANCOVA model, and can be evaluated analytically and efficiently. A fully saturated
linear model can yield asymptotically consistent estimates and confidence intervals (Lin
(2013)). This is especially problematic in medical trials, where conditions are not always
ideal for the linear model to work well: linear models can have substantial bias in small
samples (Freedman (2008)), outcomes are often discrete or ordinal, the treatment may have
a differential effect across subgroups of individuals, and when the distributions of outcomes
may differ across strata.
Permutation testing is an alternate approach (Fisher (1935); Pitman (1937, 1938)).
Deliberate randomization induces a distribution for any test statistic under the null hy-
pothesis that treatment has no effect on the outcome: the randomization scheme provides
information about all possible ways that treatment may have been assigned and the null
hypothesis tells us what each individual’s response would be regardless of the assignment
(namely, it would be the same). One determines how “extreme” the observed test statistic
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is relative to this randomization distribution, rather than a parametric reference distribu-
tion like Student’s t or the standard Gaussian. Such a test is exact, meaning that it controls
the type I error rate at the pre-specified level even in finite samples, whereas parametric
hypothesis tests based on asymptotic approximations do not always guarantee good finite
sample properties. Permutation tests condition on the observed sample and do not require
any assumptions about the way individuals were sampled from a larger population. This
is useful when the sampling frame is difficult to specify, such as when the study uses a
convenience sample.
In the past, statisticians relied on parametric methods because asymptotic approxima-
tions were a computationally feasible way to estimate distributions and construct confidence
intervals. Now, computational power is no longer a barrier to finding exact (or exact to pre-
specified precision) randomization distributions and confidence intervals. In most cases, a
randomization test is the “gold standard”: “[a] corresponding parametric test is valid only
to the extent that it results in the same statistical decision [as the randomization test]”
(Bradley (1968)). There is no hard and fast rule describing the rate at which parametric
tests approach the exact permutation solution, as they are both highly dependent on the
particular data observed. However, if the permutation test agrees with the parametric
test, one may have a greater degree of confidence in the estimates and confidence intervals
constructed using the parametric method.
We review several hypothesis tests for randomized experiments which adjust for pre-
treatment covariates to increase power to detect a nonzero treatment effect. We focus on
ANCOVA and its permutation counterparts, comparing their performance in different sce-
narios and illustrating their application with a clinical dataset. Section 2 introduces the
potential outcomes model, shows how this model is inconsistent with the assumptions of
the parametric ANCOVA, and describes permutation tests whose assumptions match this
model. Section 3 presents simulations that suggest that even in this potential outcomes
framework when various assumptions for the ANCOVA test are violated, the parametric
and permutation tests have comparable power to detect a treatment effect. In Section 4,
we apply each of the tests to data from a clinical trial comparing the performance of two
treatments for gastroesophageal reflux disease (GERD). We conclude in Section 5 with
5
implications of these results for practitioners.
2 Methods
2.1 Notation
Suppose we have a finite population of N individuals. Individuals are grouped into strata
indexed by j = 1, . . . , J , with nj individuals in stratum j and
∑J
j=1 nj = N . Of the nj
subjects in stratum j, nTj are assigned treatment 1, while the remaining nj−nTj are assigned
treatment 0. Let Zij indicate the treatment assigned to individual i in stratum j.
All individuals have two potential outcomes, Yij(1) and Yij(0), representing their re-
sponses to treatments 1 and 0, respectively. We can never observe both; random assign-
ment of treatment reveals Yij = ZijYij(1) + (1 − Zij)Yij(0). The potential outcomes are
fixed, but the observed outcome Yij is random. Throughout, we assume that there is no
interference between individuals (in other words, Yij is a function of (Zij, Yij(1), Yij(0)) and
not any other Zi′,j′ for (i
′, j′) 6= (i, j)) and that there is no censoring or non-compliance
(we actually observe Yij = Yij(Zij) for all (i, j)).
Furthermore, we observe a covariate Xij that may be associated with the outcome. For
expository clarity, we suppose that X is univariate, but all results are easily extended to
the case when X is multivariate. X may be associated with stratum membership.
We are interested in the effect of treatment, measured as differences in potential out-
comes Yij(1) − Yij(0). We can never learn this difference for any particular individual.
However, a tractable problem is to estimate the mean difference in the study sample or in
a target population. Various functions of potential outcomes may be of clinical interest;
the goal of the study and the method of analysis determine which function is considered.
We study hypothesis testing for whether these differences are nonzero using parametric
ANCOVA and its permutation counterparts, assuming this potential outcomes framework
throughout. Other valid methods for comparing two groups include using a two-sample t
test to test the difference in two means from normal distributions, the Wilcoxon rank sum
test to test for differences in the medians of two independent groups, and the Kolmogorov-
Smirnov test and receiver operating characteristic curve analyses to test whether two groups
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have different distribution functions (Lehmann (1975); Vexler et al. (2016)). We focus on
testing using the linear model as this is standard in clinical trials, requires fewer distribu-
tional assumptions on the data when using the potential outcomes framework, deals with
averages, and incorporates control variables to increase power.
2.2 Parametric ANCOVA
ANCOVA is based on a linear model with an indicator variable for membership in each
stratum. The model is
Yij = αj + βXij + γZij + εij (1)
where αj is a fixed effect for stratum j, β is the coefficient for the pretreatment covariate,
γ is the coefficient for treatment, and εij is an error term. The parameter of interest is γ,
and the parametric ANCOVA tests the null hypothesis H0 : γ = 0 against the two-sided
alternative hypothesis H1 : γ 6= 0. If the linear model is the true data-generating process,
then Yij(1) = Yij(0) + γ for all (i, j). However, we needn’t take this perspective for γ to
be a useful quantity; it represents the average treatment effect, holding the other variables
fixed.
To carry out the standard parametric hypothesis test for a linear model, the following
assumptions are needed (Freedman (2005)):
• Linearity: The data Y are related to X and Z linearly.
• Constant slopes: Stratum membership only affects the intercept αj, not the slopes
β and γ.
• IID Errors: The εij are independent and identically distributed with mean 0 and
common variance σ2.
• Independence: If X is random, ε is statistically independent of X.
• Normality: The errors are normally distributed.
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The coefficients are estimated using least squares (or equivalently, by maximizing the
likelihood). The coefficient γˆ is the estimated average treatment effect. This procedure
also yields an estimate σˆ2γˆ of the variance of γˆ. Under the null hypothesis, the test statistic
T =
γˆ√
σˆ2γˆ
follows the Student t distribution with degrees of freedom equal to the number of observa-
tions minus the number of parameters estimated (in this case, N − J − 2). The p-value for
this hypothesis test is the probability, assuming the null hypothesis of zero coefficient is
true, that a value drawn from the t distribution is larger in magnitude than the observed T .
This test is equivalent to the F test. When the model assumptions are true, it is uniformly
most powerful.
The linear model is robust to violations of its assumptions, but theoretical guarantees
tend to be asymptotic. When randomized experiments are analyzed in the parametric
framework, which assumes that treatment assignment is fixed and the errors are random,
the estimated treatment effect γˆ and nominal standard errors σˆγˆ can be severely biased
(Freedman (2008); Lin (2013)). Lin (2013) shows that running a regression with a full
set of treatment and covariate interaction terms cannot hurt asymptotic precision, and
using the Huber-White sandwich standard errors can yield asymptotically valid confidence
intervals. In small samples, the bias may still be substantial. Miratrix et al. (2013) show
that post-stratification, estimating treatment effects within groups of similar individuals
defined after data are collected, can ameliorate this bias. This is equivalent to estimating a
fully saturated linear model with interaction terms for treatment and stratum membership.
The linear ANCOVA model does not account for variation in the treatment effect across
strata in this way; if the difference in potential outcomes is heterogeneous across strata,
then the coefficient γ may be attenuated towards 0. Thus, it is unclear for any particular
dataset whether or not the ANCOVA model will give valid results.
2.3 Stratified permutation test
All permutation tests essentially have two requirements: a conditioning space, the orbit
of a finite group of transformations of the data in which all configurations of the data
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are equiprobable under the null hypothesis, and a set of sufficient statistics for the data
which describe the data under these transformations.(Pesarin and Salmaso (2010)). In
experiments, the only random quantities are those involving Z, the vector of treatment
assignments. In particular, the potential outcomes and covariates are fixed in the finite
population under study, while the observed responses change with Z. The exact permuta-
tion inference is derived from the conditioning space which includes all possible values of
Z.
Suppose we wish to test the null hypothesis that individual by individual, treatment
has no effect. This is referred to as the “sharp” null hypothesis:
H0 : Yij(1) = Yij(0), ∀i = 1, . . . , nj, j = 1, . . . , J.
Under the null hypothesis, which treatment an individual received amounts to an arbi-
trary label. Once we observe one response under a particular treatment, we can impute the
other potential outcome; namely, it would have been the same (Rosenbaum (2002)). Thus,
the observed Yij form a sufficient statistic for the data (Pesarin and Salmaso (2010)). This
null hypothesis is stronger than the null hypothesis for the parametric ANCOVA, which
only asserts that differences in potential outcomes are zero on average.
In an experiment with complete randomization, any of the possible allocations of treat-
ment that assign nTj out of nj individuals to treatment 1 in stratum j, for each stratum
j = 1, . . . , J , has equal probability. We can construct the permutation distribution of any
statistic under the null hypothesis by imputing the unobserved potential outcomes using
the sharp null hypothesis and by re-randomizing treatment assignments using this princi-
ple of equal probabilities. The experimental design specifies the permutation scheme; no
additional assumptions are needed to find the distribution of any statistic. In practice, the∏J
j=1
(nj
nTj
)
possible allocations of treatment may be too numerous to compute the statis-
tic for each one. Instead, we typically use Monte Carlo simulations to randomly assign
treatment and compute the statistic of interest a large number of times to approximate the
randomization distribution to a desired degree of accuracy.
To summarize, the assumptions for the stratified permutation test are the following.
• Complete randomization: the ∏Jj=1 (njnTj ) assignments of treatment which assign
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nTj out of nj individuals to treatment 1 in stratum j, for each stratum j = 1, . . . , J ,
has equal probability
• No treatment effect under the null: both potential outcomes are identical and
equal to the observed outcome for each individual (i, j)
The most commonly used statistic is the difference in mean outcomes of subjects who
received treatment 1 and the mean outcomes of subjects who received treatment 0. This
statistic is unbiased over all possible random assignments of treatment which preserve the
number of treated individuals, is interpretable, and has convenient theoretical properties
owing to it being the difference of two means. However, the difference in means may not
be optimal if we want to detect heterogeneous effects. For an extreme example, imagine
that the sample contains an equal number of males and females, and each treatment is
assigned to half of males and half of females. Everybody who receives treatment 0 has an
outcome of 0, but males who receive treatment 1 have an outcome of 1 and females who
receive treatment 1 have an outcome of −1. Then the difference in means between the
treatment groups is 0, even though the treatment had nonzero effects on both males and
females. This differential effect gets averaged out.
To avoid this, one may want to account for the stratification. One way to construct a
stratified test is to use the same stratified permutation scheme but a different statistic which
combines the stratum-specific statistics into a single value, for instance taking the sum of
their absolute values. Taking the absolute value before summing ensures that effects with
different signs do not cancel each other out. Another way to construct a test is to use the
nonparametric combination (NPC) framework proposed by Pesarin and Salmaso (2010). In
this framework, the “global” null hypothesis of no effect whatsoever is decomposed into the
intersection of “partial” null hypotheses of no treatment effect within each stratum. For
NPC, one first conducts each partial test separately, then combines their p-values in a way
that preserves dependencies. For a randomized experiment, this method is equivalent to
combining stratum statistics directly, because treatment is independently assigned across
strata.
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2.4 Permutation tests with the linear model
The tests in Section 2.3 only use information on the treatment and the outcome. However,
experimenters typically record additional covariates that may be predictive of the outcome.
Incorporating these covariates can reduce variation in the statistic due to factors unrelated
to treatment, thereby increasing power to detect a treatment effect. The permutation
tests in this section use the linear model in Equation 1 to control for covariates, but
make different assumptions about the data. In a randomized experiment, the treatment
assignment is independent of covariates, errors, and potential outcomes, making several
variables exchangeable. We show two permutation tests developed in this framework.
They test the same “sharp” null hypothesis of no treatment effect.
The first linear model permutation test is a variation on the stratified permutation
test described in Section 2.3. The assumptions are the same. The only difference is the
test statistic: this test uses the t statistic for the regression coefficient of Z in the linear
model in Equation 1. Rather than using the t distribution to calculate the significance
of the observed t statistic, we construct the permutation distribution of the t statistic by
simulation. Again, the experimental design specifies the randomization distribution and
no additional assumptions are needed: Z is independent of (Y (1), Y (0), X) conditional on
strata.
Freedman and Lane (1983) propose an alternative test based on the residuals of the
linear regression. They take an alternative view of the problem: instead of assuming the
data are generated according to the linear model Equation 1, they define the errors εij to
be the difference between the observed outcome Yij and the data’s linear projection onto
the plane αj + βXij + γZij. The ε are fixed approximation errors in this framework, not
independent and identically distributed random errors.
If the null hypothesis is true, then γ = 0 and εij = Yij − αij − βXij for all i =
1, . . . , nj, j = 1, . . . , J . Therefore, we may estimate the errors by εˆ = Y − Yˆ , where Yˆ is
the vector of fitted values from the regression of Y on X but not Z. The εˆ approximate
the true errors ε from the true data-generating process, assuming that the null hypothesis
is true. Furthermore, under the null hypothesis, the ε are independent of Z within strata.
We can carry out an approximate permutation test by permuting the estimated εˆ within
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strata, independently across strata. The test is only approximate because we must estimate
α and β to construct εˆ. The test has two important assumptions pertaining specifically to
the linear regression, on top of the two necessary pieces of a permutation test:
• Linear model: the linear model that describes Y using X and the approximation
error ε holds
• Linear regression fit: the linear regression residuals εˆ are a good approximation
to the true errors ε
• Exchangeable errors: the ε are exchangeable against X within strata; any config-
uration of the ε amongst the units has the same probability
• No treatment effect under the null: the ε do not depend on Z
The εˆ may not even be approximately exchangeable within strata if the regression
does not describe the relation between Y and X well. For this reason, Freedman and Lane
(1983) advise against using the method if there are large outlier values in the covariate X or
when X and Z are highly colinear. Randomization does not guarantee the exchangeability
against X, so this assumption should be checked. One way, suggested by Freedman and
Lane (1983), is to visually inspect a scatterplot of the residuals against X. One may
also test for association between X and εˆ, such as a stratified permutation test using the
correlation as a statistic, independently within each stratum and use the nonparametric
combination of tests to obtain a single p-value (Pesarin and Salmaso (2010)).
To summarize the steps for constructing a permutation distribution:
1. Regress Y on X and stratum indicators, but not Z to obtain Yˆ . Estimate the errors
by εˆ = Y − Yˆ .
2. Permute the εˆ within strata to obtain permuted errors εˆpi.
3. Construct permuted responses Y pi = Yˆ + εˆpi.
4. Regress Y pi on X, Z, and stratum indicators. The test statistic is the t statistic for
the coefficient of Z.
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Others have developed variants on these approximate regression-based permutation
tests. There is some disagreement on what constitutes an appropriate permutation scheme.
Manly (2006) proposed randomizing the outcomes Y , treating them as though they were
randomly assigned to pairs (X,Z) under the null hypothesis. Permuting data this way cor-
responds to the null hypothesis that all coefficients are 0 in the linear model, which may not
reflect the true relationship between variables. Kennedy (1995) proposed a permutation
method similar in spirit to Freedman and Lane (1983), but which differs procedurally. Both
methods attempt to measure the correlation between treatment and unexplained variation
in outcomes, but instead of regressing pseudo-outcomes Y pi on covariates to obtain a per-
mutation distribution, Kennedy (1995) recommends using the t statistic from regressing Z
on the permuted residuals εˆpi.
Several authors have compared these tests theoretically and empirically (Anderson and
Legendre (1999); Anderson and Robinson (2001); Kennedy and Cade (1996)). They find
that the Freedman-Lane test of residuals is asymptotically equivalent to the “oracle” exact
hypothesis test which we could conduct if we knew which permutations of Y given X were
equiprobable under the null hypothesis (Anderson and Robinson (2001)). This agrees with
empirical results, which show that the Freedman-Lane test performs better than other
linear model permutation tests in simulations, though its advantage is small (Anderson
and Legendre (1999)). Therefore, throughout the rest of the paper we focus on the two
linear regression permutation tests we described in detail: linear regression with permuted
treatment assignments and the Freedman-Lane method of permuting residuals.
3 Simulations
We simulated data from a randomized experiment using several different data-generating
processes. The variables included stratification, two randomly assigned treatments, a base-
line measure before treatment, and the same variable measured after treatment. We tested
for a treatment effect and compared the empirical power of the tests over repeated random
treatment assignments. We compared the following tests: the t test from the parametric
ANCOVA, a stratified permutation test using the difference in mean outcomes as the statis-
tic (called “stratified permutation” in what follows), a stratified permutation test based
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on the t statistic from the linear regression of outcome on control variables (called “LM
permutation” in what follows), and the Freedman-Lane permutation test. The simulation
code is included in four supplementary files. The supplementary files additionally con-
sider a stratified permutation test using the mean change scores, defined as the difference
between the outcome and baseline measure; we omit the results here.
3.1 Continuous outcomes
In the first set of simulations, we generated continuous potential outcomes based on a latent
variable and disturbance terms, both of which we manipulated. We used two scenarios. In
the first scenario, the treatment effect was homogeneous across strata. We drew a latent
random variate vij from the uniform distribution on [−4, 4]. In the second scenario, the
treatment effect was heterogeneous across strata, and we drew the latent random variable
according to
vij ∼

Unif[−4,−1] : j = 1
Unif[−1, 1] : j = 2
Unif[1, 4] : j = 3
We generated independent and identically distributed errors εij and δij and varied the
error distribution. The errors were either standard normal (to mimic the usual ANCOVA
assumptions), t distributed with two degrees of freedom, standard lognormal, or exponen-
tially distributed, with scale parameter 1 and shifted to have mean zero. The observed
(vij, εij, δij) were independent across i and j.
We included nj = 16 individuals per stratum and treatment assignment was balanced,
i.e. 8 people received each treatment in each stratum. After sampling (vij, εij, δij), we
constructed the baseline value for individual i, j as
Xij =
−γevij + evij/2
2
+ εij.
γ was a fixed constant. Then we generated potential outcomes as
Yij(Zij) =
(2Zij − 1)γevij + evij/2
2
+ δij.
This is equivalent to the following linear data-generating process:
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Yij(Zij) = Zijγe
vij +Xij + (δij − εij).
This model does not exactly match the ANCOVA Equation 1 and only some of the assump-
tions are satisfied: Y is linear in (X,Z) conditionally on the latent variable v, the errors
are independent and identically distributed, and are independent of X. When the latent
variables vary in distribution across strata, the assumption of constant slopes is violated.
We regenerated Z and the potential outcomes Y (Z) 10,000 times. We repeated this
procedure for each distribution of latent variables v and of the errors ε and δ. The treatment
effect for individual (i, j) was γevij . We tested whether the treatment had a nonzero effect
in the sample using each of the tests described.
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Figure 1: Empirical power ratio curves for the continuous simulated data with normally
distributed ε and δ, showing the ratio of the rejection rate of the test to the rejection
rate of the parametric ANCOVA. The left panel shows power when the treatment effect
was constant across strata and the right panel shows power when the treatment effect was
heterogeneous.
First, we studied how power changed with the average treatment effect. We used
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normally distributed errors and varied γ from 0 to 0.2 in steps of 0.05. In the random
populations that were generated, this corresponded to population average treatment effects
of 0, 0.34, 0.68, 1.02, and 1.36 respectively. When the treatment effect was homogeneous
across strata, all the tests had the correct level of 5% (i.e. the power when γ = 0). The left
panel of Figure 1 shows the empirical power (rate of rejection in the 10,000 simulations) at
level 5%, relative to the empirical power of the ANCOVA, for these increasing effect sizes.
A ratio of one indicates that the test had the same power as the ANCOVA, while a ratio
above or below 1 indicates that power was higher or lower, respectively, than the power of
the ANCOVA. The permutation linear model tests performed comparably and are plotted
on top of each other, while the stratified permutation test had slightly more power.
The right panel of Figure 1 shows the empirical power ratios at level 5% for the same
experiment, with heterogeneous treatment effects across strata. Three of the four tests
had the correct level of 5%, while the stratified permutation test rejected only 1% of the
time. The stratified permutation had lower power than the linear model tests as the effect
size increased. The correlation between baseline X and outcome Y was low but nontrivial
(between 0.04 and 0.44), so this result makes some sense: it is beneficial for power to control
for the baseline in the linear model.
Finally, we varied the distributions of the errors ε and δ and examined the power of
the four tests. Recall that these are not errors in the linear model framework, but rather
disturbances on the potential outcomes and baseline measures for each individual. These
disturbances affect the distributions of X and Y , which may impact the power of the
parametric ANCOVA and may make it beneficial to control for the baseline. We fixed
γ = 0.2 and let the errors have a standard normal distribution, a normal distribution with
variance depending on the magnitude of X (either standard deviation of 1 if |X| ≤ 1 or
standard deviation of 2 otherwise), a t distribution with 2 degrees of freedom, a standard
log normal distribution, or an exponential distribution with parameter 1, shifted to have
mean zero.
The top panel in Table 1 shows the empirical power for each of these error distributions
and tests, where the vij came from a single distribution across strata. In all cases, the
correlation between baseline and outcome was lower than 0.05 in magnitude. Thus, the
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stratified permutation test, which omits the baseline measurement, had the highest power
for all error distributions. All three linear model based tests had roughly the same rejec-
tion rate. Power was highest for the homoskedastic normally distributed errors and was
lowest for the heteroskedastic normally distributed errors. The scenario with correlated
errors violates both the ANCOVA assumption of IID errors and the Freedman-Lane test
assumption that errors are exchangeable against X.
The bottom panel of Table 1 shows the results when the distribution of vij varied across
strata. In this case, the three linear model based tests had the highest power for each error
distribution. While the correlation between baseline and outcome was still nearly zero,
controlling for it in the linear model tended to increase precision. Conversely, the stratified
permutation test lost power for this reason. Interestingly, when the errors were t or log
normally distributed, the power of each test did not change much whether the treatment
effects were constant or heterogeneous across strata. Perhaps surprisingly, the power of
the linear model tests was higher when effects were heterogeneous than when they had the
same distribution across strata. In this scenario, the linear model does not fully describe
the relationship between baseline and outcome: interaction terms between baseline and
stratum ID are needed in the model to capture this variation across strata.
Treatment
Effect
Errors ANCOVA
Stratified
Permutation
LM
Permutation
Freedman-Lane
Constant
Normal 0.835 0.874 0.842 0.841
Normal, heter. 0.503 0.541 0.509 0.511
t(2) 0.440 0.481 0.448 0.450
Log Normal 0.687 0.709 0.696 0.698
Exponential 0.780 0.820 0.793 0.791
Heterogeneous
Normal 0.877 0.844 0.887 0.891
Normal, heter. 0.633 0.631 0.644 0.643
t(2) 0.543 0.512 0.550 0.551
Log Normal 0.711 0.608 0.730 0.731
Exponential 0.814 0.786 0.820 0.816
Table 1: Empirical power at level 0.05 for simulated data with homogeneous treatment
effects (top panel) and heterogeneous treatment effects (bottom panel).
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3.2 Discrete outcomes
Many medical outcomes are measured on a discrete, ordinal scale, but the same regression-
based methods designed for continuous data are used to test for a nonzero treatment effect.
These data do not satisfy the ANCOVA assumptions of linearity and of normally distributed
errors. We repeated the procedure above, instead discretizing the covariate X and potential
outcomes Y (Z) by removing their fractional parts. We used the same distributions for the
latent variables v. We drew ε and δ from independent standard normal distributions, and
again we varied γ and the population average treatment effect in the same way.
The left panel of Figure 2 shows the empirical power at level 5% relative to the empirical
power of the ANCOVA for these increasing effect sizes when treatment effects were homo-
geneous. When the effect size was zero, all four tests had the correct level of 5%, though the
stratified permutation test rejected 3.5% of the time. In this case, the unadjusted stratified
test had comparable power to the linear model based tests. The right panel of Figure 2
shows the empirical power ratios when treatment effects varied across strata. The patterns
are similar to when outcomes were continuous. It is interesting to note that for the discrete
outcomes, all of the tests had more power when treatment effects were heterogeneous.
3.3 Imbalanced treatment groups
Many experiments use assign a different number of individuals to each treatment group.
Our previous simulations assumed that the number in each treatment group was the same.
We examined the effect of varying the proportion who received treatment in each stratum.
The tests remain consistent no matter how many individuals are assigned to each treatment
group, but power may be affected.
We repeated the simulations with continuous outcomes, Gaussian disturbances, and
fixed γ = 0.2 but varied the number of treated in each stratum to be 4, 8, or 12. Each of
the tests tended to have higher power when the total number of treated units was around
half of the population (in this case, 24 out of 48). It is interesting to note that all tests
had more power when 25% of units were treated than when 75% were treated; it seems
that power is not a symmetric function. In the scenarios with a varying treatment effect,
the effect was largest in the third stratum and smallest in the first stratum. As expected,
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Figure 2: Empirical power ratio curves for the discrete simulated data, showing the ratio
of the rejection rate of the test to the rejection rate of the parametric ANCOVA. The left
panel shows power when the treatment effect was constant across strata and the right panel
shows power when the treatment effect was heterogeneous.
among experiments that fixed the total number of treated units, the experiment with more
treatment units in the third stratum tended to have higher power.
The unadjusted stratified test had comparable power to or higher than the linear model
based tests. ANCOVA had slightly higher power than the linear model permutation tests
for all experiments except for when the number of treated units was equal to number of
controls and when the number of treated units was 30 or above. Overall, these differences
were not practically significant. We refer the reader to the supplementary file for the details
of these experiments.
3.4 Nonlinear model
The potential outcomes model we used before turned out to be a linear function of X and Z,
conditional on the latent variable v. For these simulations, we changed the outcome model
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to be nonlinear, violating an important ANCOVA assumption. Instead of an additive
treatment effect, now the effect is multiplicative. We generated the latent variable and
errors in the same way, but let
Xij =
evij + evij/2
2
+ εij
Yij(Zij) = (1 + γ)
ZijXij + δij
= γXijZij +Xij + δij.
The treatment effect for individual (i, j) is thus γXij. The stratified, unadjusted per-
mutation test failed here: the potential outcomes depend on the baseline covariate, so units
are not exchangeable without controlling for the baseline. The ANCOVA and permuta-
tion linear model tests had identical power. The patterns were the same when the latent
variables v had the same and different distributions across strata; it made little difference
because the treatment effect varied within strata due to the dependence on the baseline
covariate.
4 Clinical data results
We compared the parametric ANCOVA, the stratified permutation test, and the two linear
model-based permutation tests using a dataset from a clinical trial comparing the effective-
ness of two treatments for gastroesophageal reflux disease (GERD). A detailed discussion
of the data and analysis is provided in a supplementary file. We summarize the analysis
here. Patients were treated at eight sites in two different countries. At each site, patients
were randomly assigned one of two treatments. Patients were observed for a week before
receiving treatment and for a week after receiving treatment. On each of the fourteen
days of observation, patients responded to a survey about their heartburn, regurgitation,
and dyspepsia frequency and severity. These endpoints were measured on a discrete scale.
There were several additional endpoints calculated from the survey measures: daily heart-
burn, daily regurgitation, daily “hrdq” (a composite score), and daily dyspepsia. Daily
“hrdq” was the primary endpoint. To reduce day-to-day variation, we averaged the mea-
sures from each week to obtain two observations per patient, one pre-treatment and one
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post-treatment. These averages are not quite discrete ordinal values, but they are not
continuous either: they can only take a finite set of values.
We used site as the stratification variable, as this is the level at which treatment was
randomized. The model used for the linear regression-based tests was defined as in Equa-
tion 1. This model allowed the intercept αj to vary across sites and used the pretreatment,
baseline measurement as the control variable X. The outcome and baseline had a moder-
ate correlation (for instance, the correlation ranged from 0.56 for daily “hrdq” and 0.70 for
heartburn frequency). Frison and Pocock (1992) recommend using change scores only if the
correlation is at least 0.5. However, we choose to include the baseline as a covariate in the
linear regression, rather than using change scores as the dependent variables, to illustrate
the inclusion of covariates and to be consistent with the original analysis of the data.
Table 4 shows the mean and standard deviation of each clinical endpoint for the two
treatment groups. There is a large difference in means for daily heartburn (“daily heart”),
daily “hrdq” (“daily hrdq”), heartburn frequency (“heart freq”), and regurgitation fre-
quency (“regurg freq”). The difference is less clear for daily regurgitation (“daily regurg”),
daily dyspepsia (“daily dysp”), and dyspepsia frequency (“dysp freq”). The distribution
of outcomes for each endpoint is extremely right skewed, which may make it difficult to fit
a linear model to the data. Residual plots indicate heteroskedastic errors, invalidating the
assumption of constant error variance needed for parametric inference. The permutation
test assumptions are guaranteed by the randomization that was conducted. We checked the
additional exchangeability conditions for the Freedman-Lane test and found no evidence
that they were violated. These checks are included in the supplementary file.
Table 4 shows the p-values for the four tests and the seven continuous study endpoints.
Overall, the results confirm our expectations based on visual comparison in Figure ??:
one or more of the tests reject the null hypothesis that outcomes are the same between
treatments for heartburn frequency, daily heartburn, and daily “hrdq,” but not for any of
the other endpoints. The p-values for the stratified, unadjusted permutation test have no
consistent pattern: sometimes they are smaller than the p-values from the other tests and
sometimes they are larger.
The three tests based on the linear model give qualitatively similar results here. The
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Mean A SD A Mean B SD B
daily heart 0.59 0.46 0.75 0.52
daily regurg 0.52 0.44 0.58 0.45
daily dysp 0.56 0.51 0.55 0.49
daily hrdq 1.11 0.84 1.33 0.86
heart freq 2.48 2.10 3.51 2.76
regurg freq 2.30 1.97 2.58 2.16
dysp freq 2.49 2.48 2.36 2.25
Table 2: Mean of each continuous outcome in groups A and B.
ANCOVA p-values tend to be smaller than the permutation linear model and residual
permutation test p-values. This may be due to the skewed outcome distributions and
heteroskedastic errors: the parametric test is more sensitive to large values than the per-
mutation tests. Our conclusions for the heartburn frequency, daily heartburn, and daily
“hrdq” endpoints differ between ANCOVA and the permutation tests at significance level
0.05, but not at level 0.1. There is no endpoint which would be deemed significant using a
permutation test but insignificant with ANCOVA. This suggests that the parametric test
correctly discriminates between endpoints that are significantly different and endpoints
that are not different between treatment A and treatment B. The correspondence between
parametric and permutation test results gives some confidence that the results are stable
and reliable.
5 Discussion
This paper adds to the literature comparing parametric and nonparametric tests. We sim-
ulated a variety of data-generating processes under the potential outcomes model, ranging
from the ideal case when treatment effects are homogeneous for all individuals, to cases
when errors are heavy-tailed or heteroskedastic, data are discrete, effects vary across strata,
and treatment assignment is imbalanced within groups. The linear regression based tests
had comparable power in all circumstances. They all suffered a loss of power when the
linear model was a poor fit to the data. The stratified permutation test appears to perform
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Endpoint ANCOVA
Stratified
Permutation
LM
Permutation
Freedman-Lane
heart freq 0.035 0.003 0.070 0.074
regurg freq 0.136 0.157 0.231 0.221
dysp freq 0.565 0.925 0.592 0.579
daily heart 0.032 0.010 0.062 0.069
daily regur 0.142 0.195 0.250 0.243
daily hrdq 0.043 0.033 0.086 0.088
daily dysp 0.582 0.803 0.686 0.699
Table 3: Comparison of p-values from four tests, for each continuous endpoint.
best when the correlation between the outcome and covariates is low, while using change
scores as the dependent variable in the stratified permutation test works best when the
correlation is high. The linear model permutation tests are a middle ground between these
two extremes: they allow one to incorporate covariates with any amount of correlation,
assuming that the linear model has a reasonable in-sample fit. It is a matter of taste which
test one chooses for their experiment: while the parametric test may be robust to viola-
tions of its assumptions, it seems reassuring that the permutation test can exactly match
the randomization that was done without additional assumptions. Applying a linear model
based permutation test as a secondary analysis can give insight into how strongly violations
of the ANCOVA assumptions affect results and give confidence that inferences based on
ANCOVA are reliable.
On the one hand, some argue that violations of parametric test assumptions necessitate
the use of permutation methods. Ludbrook and Dudley (1998) point out that medical
trials rarely follow the population sampling model that is implicit in parametric methods,
while permutation tests condition on the sample at hand. Many people recommend using
permutation tests in place of common parametric tests, such as ANOVA and generalized
linear models (Still and White (1981); Winkler et al. (2014)). They argue that there are a
myriad of ways that the data may violate the necessary assumptions for the test, and so
permutation tests are more robust.
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However, parametric and nonparametric tests seem to perform similarly when com-
pared side-by-side in simulations, even when data violate the assumptions of the parametric
method. Medical trials often use Likert scales to score pain or symptom severity, resulting
in discrete data that does not match the normality assumptions of parametric tests. How-
ever, de Winter and Dodou (2010) found that the two sample t test and Mann-Whitney
test had comparable Type I and II error rates for five-point Likert scale data, suggesting
that the violation of normality does not entirely invalidate the parametric test. Vickers
(2005) compared the parametric ANCOVA to the Mann-Whitney rank test in the context
of randomized experiments, finding that except in extreme situations, ANCOVA was more
powerful than the nonparametric test. Most similar to our question of study, Anderson and
Legendre (1999) found little difference between several permutation tests for coefficients in
a linear model alongside the parametric t test. In these situations, the permutation test
strengthens conclusions by giving evidence that the parametric test is robust to departures
from its assumptions. Our results match those of Vickers (2005) and Anderson and Legen-
dre (1999), where parametric ANCOVA and regression-based t tests performed the same
or better than the comparable nonparametric tests.
In randomized experiments, permutation tests are always valid as long as they match
the randomization scheme that was actually conducted. The exchangeability of treatments
is guaranteed by construction. In observational studies, one must prove that subjects are
exchangeable. Romano (1990) warns against using permutation tests naively if items are
not truly exchangeable. For instance, he points to the case where observations have unequal
variances. This is a problem in practice as one cannot observe errors; it is a leap of faith
to assert that they are homogeneous and therefore exchangeable. Boik (1987) illustrates
this phenomenon using the traditional F test and its permutation counterpart, and demon-
strates by simulation that the latter has larger than nominal level when the error variances
are unequal. Randomized experiments mitigate this problem: by definition, treatment as-
signment is statistically independent of all other variables (possibly conditioning on strata)
and in expectation over repeated randomizations, the two groups have equal variances.
It is important to note that the permutation tests described here are exact only in
the context of randomized experiments. Treatment is assigned at random and is therefore
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statistically independent of the covariates X and the errors ε. In observational studies,
treatment may be associated with X, ε, or both, often in a way that is difficult or impossible
to model. The statistical independence guaranteed by randomized experiments enables
us to construct permutation distributions while holding X fixed. When exchangeability
doesn’t hold, we cannot disentangle the effect of Z from the effect of X. One must provide
evidence that variables in observational studies are exchangeable in order to achieve an
approximately exact test. The onus is on the researcher to make the case that the variable
being permuted is uncorrelated with the other variables being held fixed. This can be done
visually using scatterplots, residual plots, hypothesis tests, and from knowledge of how the
data arose and were collected.
Our simulations demonstrate that the method of controlling for baseline covariates mat-
ters. The naive way to control for repeated measures is to use change scores, the difference
between the outcome and baseline measures, as the dependent variable. Simulations in the
supplementary files confirm the suggestion of Frison and Pocock (1992) to use change scores
only when there is a strong correlation between baseline and outcome. Weak correlations
between baseline and outcome occur often in practice, as was the case with our GERD
dataset. When the correlation is weak, the test of change scores may be less powerful than
ignoring the baseline altogether. Instead, we suggest incorporating the baseline in a regres-
sion model. This is more general than using differences; treating the change scores as the
dependent variable is a special case of the linear regression that constrains the coefficient
of the baseline measure to be 1. The regression approach is more flexible and demonstrably
more powerful.
SUPPLEMENTARY MATERIAL
All files are also available at https://github.com/kellieotto/ancova-permutations.
Continuous outcomes simulations: Simulations using continuous outcomes in Section 3,
including code and results. (PDF)
Discrete outcomes simulations: Simulations using discrete outcomes in Section 3, in-
cluding code and results. (PDF)
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Imbalanced treatment simulations: Simulations using continuous outcomes with vary-
ing proportions receiving treatment in Section 3, including code and results. (PDF)
Nonlinear model simulations: Simulations using a nonlinear model of potential out-
comes in Section 3, including code and results. (PDF)
Clinical trial data: Dataset used in Section 4 to compare methods. (csv)
README: Data descriptor file. (txt)
Results: Detailed explanation, code, and results of comparing methods using the clinical
trial dataset in Section 4. (PDF)
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